Japanese drugmaker Takeda will launch a new subsidiary in Tel Aviv, the company said today. The announcement marks the sixth “sales entity” the company has opened this year, following Algeria, Peru, Singapore, Ecuador and Vietnam. Takeda Israel Ltd. will supervise sales and marketing for the drugmaker’s portfolio in the region. The company couched this as another evolutionary step in its plan to “reinforce growth markets.”